Opus Genetics, Inc. earnings per share and revenue

IRD earnings per share for the last quarter are -0.29 USD whereas the estimation was -0.24 USD which accounts for -22.11% surprise. Company revenue for the same period amounts to 3.87 M USD despite the estimated figure of 2.28 M USD. Estimated earnings per share for the next quarter are -0.06 USD, and revenue is expected to reach 8.83 M USD. Also watch annual changes over time to get a bigger picture of IRD earnings per share and revenue dynamics.